Ziopharm expected to rebound By: MarketMinute.com Stock News April 14, 2015 at 17:53 PM EDT Mad Money's Jim Cramer expects Ziopharm Oncology Inc. (Nasdaq: ZIOP) to rebound. Shares of the biotechnology firm climbed $1.41 to close at $11.64. Related Stocks: Ziopharm Oncology IN